HSV-1 gG Envelope Protein Antibody (7F5): sc-56984

HSV-1 gG Envelope Protein Antibody (7F5) is a mouse monoclonal IgG2a antibody that detects HSV-1 gG Envelope Protein of Herpes Simplex Virus 1 origin by western blotting (WB) and immunofluorescence (IF). HSV-1 gG Envelope Protein (7F5) antibody is available as the non-conjugated anti-HSV-1 gG Envelope Protein antibody. HSV-1 gG Envelope Protein plays a crucial role in viral evasion of host immune response and facilitates viral entry into host cells. HSV-1 gG Envelope Protein interacts with various host cell receptors, enabling virus attachment and fusion with host cell membrane. Through receptor binding, HSV-1 gG Envelope Protein aids in viral entry and modulates immune response, allowing viral establishment and maintenance of latency within sensory ganglia. HSV-1′s ability to remain dormant in nerve cells creates treatment challenges due to potential reactivation and recurrent infections. Understanding HSV-1 gG Envelope Protein function remains essential for developing therapeutic strategies that could disrupt these interactions and lead to more effective HSV infection treatments.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

HSV-1 gG Envelope Protein Antibody (7F5) References:

1. Herpes simplex virus type 2 (HSV-2) infection in women attending an antenatal clinic in the South Pacific island nation of Vanuatu.  |  Haddow, LJ., et al. 2007. Sex Transm Dis. 34: 258-61. PMID: 16940899
2. The microenvironment of vulvar skin in women with symptomatic and asymptomatic herpes simplex virus type 2 (HSV-2) infection.  |  Löwhagen, GB., et al. 2006. J Eur Acad Dermatol Venereol. 20: 1086-9. PMID: 16987263
3. Development and validation of a capillary electrophoresis method for the characterization of herpes simplex virus type 1 (HSV-1) thymidine kinase substrates and inhibitors.  |  Iqbal, J., et al. 2007. J Chromatogr B Analyt Technol Biomed Life Sci. 846: 281-90. PMID: 17023224
4. The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity.  |  Golembewski, EK., et al. 2007. Exp Neurol. 203: 381-93. PMID: 17046754
5. Association between HSV-2 and HIV-1 viral load in semen, cervico-vaginal secretions and genital ulcers of Thai men and women.  |  Chu, K., et al. 2006. Int J STD AIDS. 17: 681-6. PMID: 17059638
6. HSV infection and immunosuppression.  |  Sindhi, R. 2006. Liver Transpl. 12: 1906-7. PMID: 17133569
7. Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas.  |  Robe, PA., et al. 2007. Int J Oncol. 30: 283-90. PMID: 17143539
8. Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts.  |  Margolis, TP., et al. 2007. J Virol. 81: 1872-8. PMID: 17151134
9. HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles.  |  Legoff, J., et al. 2007. Virol J. 4: 2. PMID: 17207276